Raymond James Financial’s Utah Medical Products UTMD Stock Holding History

Raymond James Financial’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$322K	Buy	+5,201	New	+$328K	﹤0.01%	4620

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James Financial's UTMD Position: Q1 2026 in Review

Raymond James Financial opened a new position in Utah Medical Products (UTMD) in Q1 2026: 5,201 shares worth $322K. The stake represents ﹤0.01% of the portfolio and ranks #4620 among its holdings.

119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

Raymond James Financial held 5,201 shares of Utah Medical Products worth $322K as of Q1 2026.
Utah Medical Products was a new Raymond James Financial position in Q1 2026.
Utah Medical Products made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4620 holding.
119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.